FIELD: medicine, pharmacology, steroids. SUBSTANCE: invention relates to the use of compound of the formula (I) α as an antialcoholic and adaptogenic agent. EFFECT: enhanced effectiveness of agent. 1 dwg, 3 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
DIHYDROXYPREGN-4-ENE-3,20-DIONE 17α-21-PIVALOATE ELICITING ANTIALCOHOLIC AND ANXIOLYTIC ACTIVITY | 1999 |
|
RU2171810C2 |
USING α-ACETATE-21-PYVALOATE-α,21-DIHYDROXYPREGN-4-ENE-3,20-DIONE AS ANTI-MORPHINE AGENT | 2005 |
|
RU2276981C1 |
APPLICATION OF 17 ALPHA-ACTATE-21 -PIVALOAT 17ALPHA, 21-DIHYDROXYPREGN-4-EN-3,20 DION AS AN AGENT REDUCING PATHOLOGICAL ATTRACTION TO COCAINE | 2007 |
|
RU2326673C1 |
REMEDY AGAINST PATHOLOGIC INCLINATION FOR ALCOHOLISM | 0 |
|
SU1828751A1 |
REMEDY FOR TREATING THE CASES OF ALCOHOL WITHDRAWAL SYNDROME | 1986 |
|
RU2038081C1 |
METHOD FOR REDUCTION OF MORBID ATTRACTION TO ETHANOL IN POSTABSTINENT PERIOD | 2007 |
|
RU2373927C2 |
ANTI-ALCOHOLIC MEANS | 2015 |
|
RU2624482C2 |
METHOD OF TREATMENT OF ALCOHOLICS | 1996 |
|
RU2136295C1 |
AGENT FOR MANAGING ALCOHOL ABSTINENCE SYNDROME | 2012 |
|
RU2521226C2 |
PHARMACEUTICAL COMBINATION FOR TREATMENT OF ALCOHOLIC DEPENDENCE | 2017 |
|
RU2681931C2 |
Authors
Dates
2001-08-20—Published
1999-07-21—Filed